Trial no.:
|
PACTR201710002669205 |
Date of Approval:
|
06/10/2017 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Influence of Addition of Dexmeditomidine or Fentanyl to Bupivacaine Lumbar Spinal Subarachnoid Anesthesia for Inguinal Hernioplasty |
Official scientific title |
Influence of Addition of Dexmeditomidine or Fentanyl to Bupivacaine Lumbar Spinal Subarachnoid Anesthesia for Inguinal Hernioplasty. |
Brief summary describing the background
and objectives of the trial
|
Background: No drug, used as adjuvant to spinal bupivacaine has yet been identified that
specifically inhibits nociception without its associated side effects.
Objectives: The purpose of this study is to compare the efficacy of dexmedetomidine and fentanyl
with spinal bupivacaine in inguinal hernioplasty. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,suarachnoid, anesthesia, inguinal, hernioplasty |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/10/2017 |
Actual trial start date |
07/10/2017 |
Anticipated date of last follow up |
01/04/2018 |
Actual Last follow-up date |
04/04/2018 |
Anticipated target sample size (number of participants) |
70 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Completed |
Publication URL |
|
|